Therapy News and Research

RSS

Pancreatitis drug blocks SARS-CoV-2 activators in the upper respiratory tract

Pancreatitis drug Camostat inhibits new SARS-CoV-2 activators identified in the upper respiratory tract. There are no therapeutics available that have been developed for COVID-19 treatment.

5 Mar 2021

New mRNA treatment appears to stop replication of flu and Covid-19 viruses

With a relatively minor genetic change, a new treatment developed by researchers at the Georgia Institute of Technology and Emory University appears to stop replication of both flu viruses and the virus that causes Covid-19.

4 Mar 2021

Researchers develop first wearable device to precisely monitor jaundice in newborns

Researchers in Japan have developed the first wearable devices to precisely monitor jaundice, a yellowing of the skin caused by elevated bilirubin levels in the blood that can cause severe medical conditions in newborns.

4 Mar 2021

Experimental safety switch reduces severity of CAR-T immunotherapy-related side effects

UNC Lineberger Comprehensive Cancer Center researchers have successfully used an experimental safety switch, incorporated as part of a chimeric antigen receptor T-cell (CAR-T) therapy, a type of immunotherapy, to reduce the severity of treatment side effects that sometimes occur.

4 Mar 2021

AI-based method for repurposing existing drugs into potential treatments for Alzheimer's

New treatments for Alzheimer's disease are desperately needed, but numerous clinical trials of investigational drugs have failed to generate promising options.

4 Mar 2021

Innovative cancer treatment effective in combating fungal infection in vitro and in mice

An innovative cell-based treatment for cancer has been found promising for the control of infections caused by fungi.

4 Mar 2021

Compound isolated from Moroccan fungus shows promise to fight triple negative breast cancer

A compound isolated from a fungus growing on the roots of a flowering plant in Morocco shows promise as a powerful opponent of aggressive triple negative breast cancer, scientists say.

4 Mar 2021

Smoking cessation drug shows potential to treat Parkinson's disease in females

Texas A&M University College of Medicine ressearchers have recently discovered that cytisine -- a smoking cessation drug commonly used in Europe -- reduces the loss of dopamine neurons in females. These findings provide potential evidence for the use of the drug to treat Parkinson's disease or stop its progression in women.

4 Mar 2021

Digital health solution helps reduce key symptoms of chronic pain

For the first time, an app has been shown to reduce key symptoms of chronic pain. A UHN-led study evaluated the impact of Manage My Pain (MMP), a digital health solution developed by ManagingLife, on patients seen at the Iroquois Falls Family Health Team, and the Toronto Western and Toronto General Hospitals.

4 Mar 2021

Cell surface marker CD47 may allow early diagnosis of severe COVID-19

A new study reports the potential of the cell surface marker, CD47, as a biomarker for hyperinflammation, a characteristic feature of severe COVID-19.

4 Mar 2021

Intrapericardial injection provides a less invasive means of treating cardiac injury

Injecting hydrogels containing stem cell or exosome therapeutics directly into the pericardial cavity could be a less invasive, less costly, and more effective means of treating cardiac injury, according to new research from North Carolina State University and the University of North Carolina at Chapel Hill.

4 Mar 2021

Health information from trusted sources can reduce depressive symptoms in teens

Depression can be a common problem for teens and adolescents, and while many treatments exist, they don't always work for everyone. A new study found that feeling more informed about their health may help teens take better care of themselves, leading to less depressive symptoms.

4 Mar 2021

COVID-19 pandemic had major impacts on childhood cancer care, shows survey

The COVID-19 pandemic has had major impacts on childhood cancer care worldwide, according to a survey of more than 300 clinicians from 200 hospitals worldwide published in The Lancet Child & Adolescent Health journal.

3 Mar 2021

Newly identified biomarker could predict response to immune checkpoint inhibitors

A team of Roswell Park Comprehensive Cancer Center researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors (ICI) shortly after patients with non-small cell lung cancer (NSCLC) initiate therapy.

3 Mar 2021

Using two different viruses to tackle tumors

An international research group led by the University of Basel has developed a promising strategy for therapeutic cancer vaccines.

3 Mar 2021

PICI awards $3 million to support early career cancer researchers

From improving immunotherapy response in childhood cancer patients, to better understanding how cancer's spread to the liver affects the body's immune system, to helping T cells stay energized to fight cancer, The Parker Institute for Cancer Immunotherapy (PICI)'s 2021 class of early career researchers award recipients are pursuing ideas that have the potential to change the face of oncology.

3 Mar 2021

New substance suppresses the growth of harmful bacteria that cause periodontitis

Targeted, efficient and with few side effects: A new method for combating periodontitis could render the use of broad-spectrum antibiotics superfluous.

3 Mar 2021

Combination of therapies may benefit patients with mitochondrial respiratory chain disorders

Researchers from the Mitochondrial Medicine Frontier Program at Children's Hospital of Philadelphia (CHOP) have demonstrated how one combination of therapies may be beneficial for patients with mitochondrial respiratory chain disorders.

3 Mar 2021

Cognitive behavioral therapy can reduce stress, improve mood in pregnant women

Perinatal depression has soared during the pandemic. But many mental health professionals are overwhelmed and can't take on new clients.

3 Mar 2021

Study suggests a new way to detect heart disease through non-invasive tool

In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potential new marker that shows cardiovascular disease may be present in a patient using an optical coherence tomography (OCT) scan -- a non-invasive diagnostic tool commonly used in ophthalmology and optometry clinics to create images of the retina.

3 Mar 2021

Therapy News and Research

Pancreatitis drug blocks SARS-CoV-2 activators in the upper respiratory tract

New mRNA treatment appears to stop replication of flu and Covid-19 viruses

Researchers develop first wearable device to precisely monitor jaundice in newborns

Experimental safety switch reduces severity of CAR-T immunotherapy-related side effects

AI-based method for repurposing existing drugs into potential treatments for Alzheimer's

Innovative cancer treatment effective in combating fungal infection in vitro and in mice

Compound isolated from Moroccan fungus shows promise to fight triple negative breast cancer

Smoking cessation drug shows potential to treat Parkinson's disease in females

Digital health solution helps reduce key symptoms of chronic pain

Cell surface marker CD47 may allow early diagnosis of severe COVID-19

Intrapericardial injection provides a less invasive means of treating cardiac injury

Health information from trusted sources can reduce depressive symptoms in teens

COVID-19 pandemic had major impacts on childhood cancer care, shows survey

Newly identified biomarker could predict response to immune checkpoint inhibitors

Using two different viruses to tackle tumors

PICI awards $3 million to support early career cancer researchers

New substance suppresses the growth of harmful bacteria that cause periodontitis

Combination of therapies may benefit patients with mitochondrial respiratory chain disorders

Cognitive behavioral therapy can reduce stress, improve mood in pregnant women

Study suggests a new way to detect heart disease through non-invasive tool

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News